key: cord-0812575-lzmw5hkh authors: Burclaff, Joseph; Bliton, R. Jarrett; Breau, Keith A.; Ok, Meryem T.; Gomez-Martinez, Ismael; Ranek, Jolene S.; Bhatt, Aadra P.; Purvis, Jeremy E.; Woosley, John T.; Magness, Scott T. title: A Proximal-to-Distal Survey of Healthy Adult Human Small Intestine and Colon Epithelium by Single-Cell Transcriptomics date: 2022-02-15 journal: Cell Mol Gastroenterol Hepatol DOI: 10.1016/j.jcmgh.2022.02.007 sha: e5bb24102aa145d3b4b03c824c595fb1cdcaa2af doc_id: 812575 cord_uid: lzmw5hkh BACKGROUND & AIMS: Single-cell transcriptomics offer unprecedented resolution of tissue function at the cellular level, yet studies analyzing healthy adult human small intestine and colon are sparse. Here, we present single-cell transcriptomics covering the duodenum, jejunum, ileum, and ascending, transverse, and descending colon from 3 human beings. METHODS: A total of 12,590 single epithelial cells from 3 independently processed organ donors were evaluated for organ-specific lineage biomarkers, differentially regulated genes, receptors, and drug targets. Analyses focused on intrinsic cell properties and their capacity for response to extrinsic signals along the gut axis across different human beings. RESULTS: Cells were assigned to 25 epithelial lineage clusters. Multiple accepted intestinal stem cell markers do not specifically mark all human intestinal stem cells. Lysozyme expression is not unique to human Paneth cells, and Paneth cells lack expression of expected niche factors. Bestrophin 4 (BEST4)(+) cells express Neuropeptide Y (NPY) and show maturational differences between the small intestine and colon. Tuft cells possess a broad ability to interact with the innate and adaptive immune systems through previously unreported receptors. Some classes of mucins, hormones, cell junctions, and nutrient absorption genes show unappreciated regional expression differences across lineages. The differential expression of receptors and drug targets across lineages show biological variation and the potential for variegated responses. CONCLUSIONS: Our study identifies novel lineage marker genes, covers regional differences, shows important differences between mouse and human gut epithelium, and reveals insight into how the epithelium responds to the environment and drugs. This comprehensive cell atlas of the healthy adult human intestinal epithelium resolves likely functional differences across anatomic regions along the gastrointestinal tract and advances our understanding of human intestinal physiology. We present a single-cell transcriptomic atlas of epithelial cells from the duodenum to descending colon using 3 intact healthy adult organs. Thorough analyses provide differentially expressed/functional genes, regional differences, murine model comparisons, and gene sets highlighting potential receptor-ligand and drug-target interactions BACKGROUND & AIMS: Single-cell transcriptomics offer unprecedented resolution of tissue function at the cellular level, yet studies analyzing healthy adult human small intestine and colon are sparse. Here, we present single-cell transcriptomics covering the duodenum, jejunum, ileum, and ascending, transverse, and descending colon from 3 human beings. METHODS: A total of 12,590 single epithelial cells from 3 independently processed organ donors were evaluated for organ-specific lineage biomarkers, differentially regulated genes, receptors, and drug targets. Analyses focused on intrinsic cell properties and their capacity for response to extrinsic signals along the gut axis across different human beings. RESULTS: Cells were assigned to 25 epithelial lineage clusters. Multiple accepted intestinal stem cell markers do not specifically mark all human intestinal stem cells. Lysozyme expression is not unique to human Paneth cells, and Paneth cells lack expression of expected niche factors. Bestrophin 4 (BEST4) þ cells express Neuropeptide Y (NPY) and show maturational differences between the small intestine and colon. Tuft cells possess a broad ability to interact with the innate and adaptive immune systems through previously unreported receptors. Some classes of mucins, hormones, cell junctions, and nutrient absorption genes show unappreciated regional expression differences across lineages. The differential expression of receptors and drug targets across lineages show biological variation and the potential for variegated responses. CONCLUSIONS: Our study identifies novel lineage marker genes, covers regional differences, shows important differences between mouse and human gut epithelium, and reveals insight into how the epithelium responds to the environment and drugs. This comprehensive cell atlas of the healthy adult human intestinal epithelium resolves likely functional differences and colon are distinct organs with overlapping and unique roles in maintaining health. The gut lumen is lined by epithelial stem and differentiated cells that renew weekly. 1 Cellular roles include absorption, ion balance, hormone production, mucus production, and signaling through the luminal-epithelial-immune axis. Although physiological functions vary along the gut, how lineages differ across the SI-colon axis is poorly understood. Single-cell RNA sequencing (scRNAseq) approaches have provided unprecedented transcriptomic resolution of cells and have shown unappreciated cellular heterogeneity. Human intestinal scRNAseq studies often analyze individual regions, with studies on adult colonic, 2-5 ileal, [6] [7] [8] and duodenal 9 epithelium available. One study compared adult human ileum and regionally unspecified colon, 6 and a recent report compiled a regional mosaic using multiple donor samples yet had few donors for some regions and provided a limited epithelial analysis. 10 Several human gut regions have sparse scRNAseq analysis available, with no scRNAseq studies analyzing differences among regions within the human SI or colon. Here, we comprehensively survey adult human gut epithelium using transplant-grade organs. scRNAseq libraries were prepared from epithelial cells from duodenum, jejunum, ileum, and ascending (AC), transverse (TC), and descending (DC) colon from 3 donors. This experimental design provides a robust library that avoids intradonor batch effects and allows comparisons between all 6 regions across the same 3 individual patients. Using this data set, we probe understudied human lineages including Paneth cells (PCs), Bestrophin 4 (BEST4) þ cells, and follicle-associated epithelium (FAE). We define comprehensive transcriptional signatures for lineages along the entire gut and generate regional atlases of functional gene families. We further probe how lineages might be affected by extrinsic signaling through mapping receptor families and analyzing primary gene targets of approved drugs. We define SI and colon as organs, and duodenum, jejunum, ileum, AC, TC, and DC as regions. Intestinal tracts were obtained from 3 disease-free organ donors ( Figures 1A and 2) , with a pathologist verifying healthy mucosa. Epithelium from each region was dissociated to single cells using cold protease to preserve RNA integrity and cells were flow-sorted to exclude dead cells and doublets before sequencing. Cells from each region were stained with cell hashtag antibody-oligo conjugates 11, 12 to multiplex regions for library preparation and sequencing, then cells from all regions per donor were sorted concurrently to avoid intradonor batch effects and reduce cost. Readouts were filtered for minimum and maximum total counts and maximum mitochondrial gene reads to exclude transcriptomes of low-read count cells, multiplets, and likely dead cells, respectively. Hashtag deconvolution allowed for more stringent filtering against clusters and contaminating messenger RNA (mRNA) than available in other studies, with cells positive for multiple hashtags removed to filter out likely multiplets or cells contaminated with RNA from other cells. After filtering, transcriptional readouts for 12,590 total cells were obtained ( Figure 2) , with consistent read depth (11,378 reads per cell) and gene counts (2851 genes per cell) seen across regions. Donor data sets were individually processed and then combined. Principal components were integrated with Harmony 13 before dimensional reduction and Leiden clustering. 14 Most lineages formed SI-and colon-specific clusters, suggesting functional differences between organs. One cluster expressed PC and goblet cell (GC) markers, so subclustering resolved these lineages ( Figure 3 ). Our final data set identifies all lineages by organ ( Figure 1B ). The integrated data set shows overlapping cell distributions from each donor and region within all major lineages, showing that postsequencing hashtag deconvolution preserves transcriptomic features across batches ( Figure 1C -E). Cell counts for each region show that all 3 donors contributed approximately one third (33%) of the total cells analyzed for each region and no individual donor provided the majority of cells for any specific region, with each donor providing 20%-48% of the total cells for every region ( Figure 2 ). To define transcriptional signatures for each lineage, we calculated differentially expressed genes (DEGs) in both organs for each lineage (Supplementary Table 1 ). We also identified DEGs consistently enriched across all 6 regions and in all 3 donors, defining DEGs that are lineage-specific regardless of position in the SI or colon (Supplementary Table 2 ). This statistical evaluation provides previously unavailable transcriptional signatures for all lineages across the human SI and colon epithelium ( Figure 1F and G). We found that human intestinal stem cells (ISCs) significantly expressed classic markers LGR5, ASCL2, SLC12A2, and RGMB ( Figure 4A and B). 15-17 SMOC2 18 was not a DEG in SI ISCs because PCs unexpectedly were found to express it at higher levels (see Paneth Cell section). Although in situ hybridization was used in a previous report that concluded that OLFM4 marks human colonic ISCs, 19 our results showed colonic OLFM4 levels were higher in transit-amplifying (TA) cells ( Figure 4C) , consistent with mouse studies. 16 RARRES2, a retinoidresponse gene with no reported association to the gut epithelium, was enriched in colon ISCs, with low SI ISC expression ( Figure 4B ). Figure 5 ). We identified 46 ISC DEGs enriched across both organs, defining an ISC transcriptional signature spanning SI and colon (Supplementary Table 2 ). This signature includes classic ISC markers and 30 ribosomal genes, consistent with transcriptional regulation by ribosomes shown in other stem cell populations. [20] [21] [22] To identify ISC DEGs conserved between human beings and mice, we compared our 68-gene SI ISC signature with a mouse ISC signature defined by bulk RNA sequencing of flow-sorted Leucine Rich Repeat Containing G Protein-Coupled Receptor 5 (Lgr5 þ ) cells. 18 Surprisingly, only 11 genes overlapped between the signatures ( Figure 4D ), although it is unclear whether this reflects species differences or the higher stringency of scRNAseq and computational analysis compared with bulk sequencing of cells sorted using a fluorescent reporter. Conserved genes included classic markers: LGR5, OLFM4, ASCL2, RGMB, SLC12A2, and MYC; genes with known ISC function: RNF43, ZBTB38, VDR, and CDK6; and 1 gene absent in ISC literature: TRIM24. These SI, colon, and full-gut ISC signatures underline key similarities and differences in proximal-distal human ISCs. Leiden clustering separated SI TA cells undergoing S/G2 cell-cycle phases (TA) and M-phase (TA2) (Supplementary Tables 3 and 4). We found that DEGs shared across SI TA, SI TA2, and colon TA cells ( Figure 4E) were involved in the cell cycle, mitochondrial biogenesis, and ribosomal RNA processing, consistent with the increased mitochondrial load and translation seen because stem cells differentiate in various systems. 20, [23] [24] [25] Several organ-specific markers of differentiated lineages ( Figure 6 ) were enriched unexpectedly in their respective SI or colon ISC and TA populations ( Figure 4F ), hinting that ISCs are transcriptionally primed for organ-specificity instead of existing in a pan-intestinal state. This is consistent with adult rodent SI ISCs producing daughter cells specific to their originating organ when engrafted into alternative sites. 26, 27 Studies defining region/ organ-specific chromatin or transcriptomic differences in human ISCs were not found; thus, these genes may aid in studying early differentiation and chromatin dynamics. Trajectory analyses computationally investigate lineage transitions and have been used previously to describe mouse physiology. [28] [29] [30] [31] We used partition-based graph abstraction (PAGA), which analyzes transcriptomic similarity between individual cells in different clusters, to define total connection strength (connectivity) between progenitor and differentiated populations and to infer temporal lineage trajectories. 32 As expected, absorptive enterocytes (AEs) and absorptive colonocyte (ACCs) are strongly and almost exclusively connected to ISCs and TA cells, 8, 33 while PCs, GCs, and enteroendocrine cells (EECs) connect strongly to the secretory progenitor population ( Figure 4G and H). Consistent with murine findings, tuft cells connect weakly but exclusively to secretory progenitors in colon but not in SI. 34, 35 Conversely, SI BEST4 þ cells connect weakly but exclusively to secretory progenitors while colonic BEST4 þ cells connect strongly to TA cells. Because the strength of a connection depends directly on the number of cells analyzed, future studies that enrich for secretory progenitors and immature but lineage-committed, crypt-base populations are needed to further strengthen these findings. Predicted regional cell-cycle phase distributions 36 were analyzed in proliferative lineages ( Figure 4I -K). ISCs showed high G1-and S-phase across regions, 6 while highly proliferative TA cells largely existed in the S and G2/M. TC showed lower proportions of TA cells in G2/M than jejunum, reflecting regional differences seen in rodents. 34 Secretory progenitors showed increasing S phase proximally to distally and higher G1 proportion than TA cells. Murine PCs play important niche-supporting and antimicrobial roles, 37 yet little scRNAseq analysis covers human PCs. Our data include 49 human PCs, 10 times more than analyzed in recent literature. 9 PCs were defined using DEFA5, DEFA6, ITLN2, and PLA2G2A ( Figure 7A ). Because PCs cluster alongside GCs and share LYZ expression with BEST4 þ cells, classic markers were plotted to confirm PC identity ( Figure 7C) . Surprisingly, the murine marker LYZ was not unique to human PCs, with expression also seen in BEST4 þ cells and high expression in FAE ( Figure 7B ). This is consistent with LYZ expression found in fetal human organoids not expected to form PCs. 38 Other human intestinal scRNAseq reports also have indicated that LYZ mRNA is not unique to PCs, with 1 report showing that LYZ is not a top PC DEG 8 and another showing LYZ as a DEG for M cells, 10 consistent with our findings ( Figure 7B, Supplementary Table 1 ). This indicates that although human PCs indeed express LYZ, the presence of this gene product alone is insufficient to determine PC identity or presence. Importantly, our data indicate the cells designated as PCs in a recent scRNAseq publication 6 are actually BEST4 þ cells because they are marked by high LYZ, SPIB, BEST4, and CA7. Similarly, the colonic Paneth-like cells reported in the study likely also are BEST4 þ cells. The rarity of PCs in scRNAseq data (<1% here and elsewhere 9 ), and the presence of LYZ mRNA in other lineages in addition to PCs, highlights the precise lineage attribution needed when defining human PCs. Murine PCs express ISC niche factors including Wnt3, Wnt11, Tgfa, Egf, Dll1, Rspo1, and Dll4, 29,37,39,40 but 1 report showed human PCs express no WNT3/11. 9 Our data confirm this and showed no measurable EGF or RSPO1 and minimal TGFA ( Figure 7D ). DLL1 and DLL4 are both expressed higher in secretory progenitors ( Figure 7D ). We found no intestinal growth factors enriched in PCs ( Figure 7E ), suggesting human PCs are not major niche-supporting cells. This agrees with nonepithelial sources of WNTs and growth factors in the human niche 38, 41 and echoes mouse biology, where PCs support ISCs 37 yet are unnecessary for niche maintenance. 37, [42] [43] [44] Unexpectedly, SMOC2, a murine ISC marker, 18 was expressed highest in PCs, with other markers shown as restricted to ISCs in mouse (LGR5, ASCL2, RGMB) expressed higher in human PCs than expected from the mouse data 45 ( Figure 7F ). Expression of SMOC2 mRNA in human PCs was visualized using in situ hybridization, with obvious overlap seen between SMOC2 and LYZ protein ( Figure 7F ). ISC-PC doublets could provide a possible explanation for these ISC genes presenting in PCs, yet the lack of many other ISC markers in PCs, notably the nearly complete absence of OLFM4, opposes this hypothesis. LGR5, SMOC2, and ASCL2 function in WNT reception, 15,46-48 suggesting human PCs receive WNT signals instead of providing WNT signals. 37 PC unique FZD9 expression further supports a WNT-receptive PC role ( Figure 7H ). Despite striking differences between mouse and human PCs, both supply antimicrobial gene products. Six of the 10 highest expressed SI antimicrobial peptides are PCenriched ( Figure 7I ). Because antimicrobial genes comprise half of human PC DEGs (Supplementary Table 1 ), PCs largely appear to function to protect the ISC niche. 49 Recent human scRNAseq studies have described a novel intestinal lineage, absent in mice, expressing BEST4, SPIB, and CA7, 5 with SI-specific CFTR 9,10 and colon-specific OTOP2. Because these cells often are described by their expression of BEST4, here we label these SI and colon clusters BEST4 þ cells. Our DEGs encompassed all of the previously defined markers for BEST4 þ cells ( Figure 8A ). By comparing with diffusion pseudotime, which infers trajectory, 50 our data suggested that BEST4 is only expressed to high levels as the cells mature ( Figure 8B ), and this was confirmed with in situ hybridization, with BEST4-high cells never seen in the proliferative crypts of SI ( Figure 8C ) or colon ( Figure 8D ). In line with previous literature, 9,10 cystic fibrosis transmembrane conductance regulator (CFTR) protein was shown to mark the apical tips of SI BEST4 þ cells ( Figure 8C ) but not colonic BEST þ cells ( Figure 8D ). With the function of BEST4 þ cells largely unknown, DEGs were used to predict their physiological roles. DEGs included GUCA2A and GUCA2B 5 , which act as prohormones regulating satiety. 51 Consistent with a previous report, we found these genes expressed in SI and colon BEST4 þ cells, 9 yet our database furthers this finding by showing that both genes are expressed higher in SI BEST4 þ cells than in colonic BEST4 þ cells ( Figure 8E ). We identified 2 previously unreported secreted peptides, NPY and BMP3, specifically in SI BEST4 þ cells ( Figure 8E ). NPY expression is unexpected in intestinal epithelium, 52 and gut BMP3 is largely studied for its antitumor roles. 53 Similar to BEST4, we found that NPY, GUCA2A, and GUCA2B expression increased with BEST4 þ cell maturation, while BMP3 was expressed independently of maturation ( Figure 8F ). Interestingly, EECs express receptors for all 4 genes, suggesting EEC-BEST4 þ cell crosstalk ( Figure 8E ). Because NPY is proposed to affect gastrointestinal (GI) motility and energy homeostasis, 54, 55 we probed if NPY correlated with genes induced after meals. We found strong positive correlations across SI regions for each donor between SI BEST4 þ cell NPY expression and AE expression of SI (R ¼ 0.82) and APOA4 (R ¼ 0.86), which are induced by dietary sugar 56 and fat 57 ( Figure 8G ). We found further positive correlations with AE genes involved in dietary metabolism (Supplementary Table 5 ), and negligible correlation with housekeeping genes ACTB (R ¼ -0.22) or GAPDH (R ¼ -0.08), suggesting postprandial induction of SI BEST4 þ NPY expression. Further SI BEST4 þ cell DEGs included ADRA2A and CHRM3, receptors involved in intestinal motility 58 (Supplementary Table 1 ), reinforcing that SI BEST4 þ cells regulate intestinal motility after meals. BEST4 þ cells likely absorb dietary heavy metals. Metallothioneins, which bind heavy metals and prevent toxicity, 59-61 were described in colonic BEST4 þ cells, 5 yet we found 7 metallothioneins specifically enriched in SI BEST4 þ cells ( Figure 8H ) alongside STEAP2, a metalloreductase for copper and iron, 62 suggesting SI BEST4 þ cells maintain SI metal ion homeostasis. [61] [62] [63] Our data indicate BEST4 þ cells perform diverse roles within the intestinal epithelium, laying the groundwork for functional studies. Tuft cells are chemosensory cells that regulate type 2 immune reactions [64] [65] [66] in the intestinal epithelium through interleukin (IL)25 signaling in response to pathogenic metabolites. 67-69 SI and colon tuft cells share many classic markers 9,70 ( Figure 9A , Supplementary Tables 1 and 2) . DCLK1, a key murine marker, 69 was not observed as a DEG. SUCNR1, a G-protein-coupled receptor mediating SI IL25 release, 71 was negligible in the colon, suggesting SI and colon tuft cells differentially detect succinate-producing pathogens ( Figure 9B and C). Colonic tuft cells likely detect umami-chemosensory cues (eg, microbe-derived free amino acids) with heterodimeric umami taste receptor subunits TAS1R1 and TAS1R3 ( Figure 9B and C). 72 Downstream taste signal transduction genes are enriched in SI and colon tuft cells, 64, 65 with SI-specific GNAT3 likely activating PDE4D to decrease intracellular cyclic adenosine monophosphate/cyclic guanosine monophosphate (cAMP/ cGMP) 73 ( Figure 9B ). This suggests human SI tuft cells have multiple responses to succinate-producing microbes (eg, Nippostrongylus brasiliensis), whereas colonic tuft cells respond to other microbial taxa. Beyond triggering type 2 immunity, tuft cell DEGs allow broad interaction with the adaptive and innate immune systems. Tuft cell DEGs implicate ubiquitin-mediated proteasome degradation, with enriched Skp, Cullin, F-box containing complex (SCF) complex components (SKP1, CUL3, FBXO32, RBX1) initiating exogenous antigen processing for presentation 74, 75 to the major histocompatibility complex 1 antigen presentation complex ( Figure 9D ). This suggests tuft cells interact with the adaptive immune system after luminal stimuli. Human tuft cells also uniquely express unappreciated Toll-like receptors (TLR9, TLR5, and TLR4), which bind bacterial/viral DNA, flagellin, and lipopolysaccharide (LPS), respectively ( Figure 9D ). [76] [77] [78] [79] Expression of the LPS co-receptor CD14 across tuft cells 77 ( Figure 9D ) supports this novel role in bacterial-related immune responses. Tuft cells show possible autoregulatory mechanisms for these pathogen-response pathways. Tuft cells express heterodimeric IL25-specific receptor components ( Figure 9D) , which may create a positive feedback loop to amplify IL25 signaling. 80 SIGIRR may also negatively autoregulate the Toll-like receptor 4-LPS response. [81] [82] [83] These implicate tuft cells as dynamic sentinels linking luminal contents to the immune system. Tuft cells produce antimicrobial peptides in the SI to complement those produced by PCs ( Figure 7G ). In the colon, which lacks PCs, tuft cells express 6 of the top 10 colonic antimicrobial peptides ( Figure 9E ). Human and murine tuft cells also produce neuromodulatory and immunomodulatory compounds. We found genes necessary for acetylcholine synthesis, communication with neurons, 84 and enzymes involved in eicosanoid and prostaglandin D 2 production, which broadly regulate inflammation 85 ( Figure 9F ). These analyses suggest tuft cells regulate luminal microbes, communicate with the nervous system, and affect systemic immune responses. GCs produce membrane-bound and secreted mucin glycoproteins that lubricate the gut, act in signaling, support commensal bacteria, and form the protective mucus barrier. 67, [86] [87] [88] DEGs include classic markers CLCA1, MUC2, and TFF3, with colonic GCs expressing higher WFDC2, consistent with previous findings 5 ( Figure 10A ). Pathway enrichment analysis of DEGs confirmed GCs principally act in mucus production and secretion, with top-enriched pathways including glycosylation, Golgi/Endoplasmic Reticulum vesicle transport, and unfolded protein response (Supplementary Table 6 ). [89] [90] [91] [92] We found secreted MUC2 and transmembrane MUC13 expressed across organs and colonenriched MUC1, MUC4, and MUC5B ( Figure 10B and C). Although GCs are considered the major intestinal mucus producers, we also mapped glycocalyx-forming transmembrane mucins, which protect against pathogenic bacteria, 93, 94 in AEs and ACCs ( Figure 10D ). GCs commonly are considered homogenous, however, GCs in the mouse colon recently were separated into functionally distinct groups, with intercrypt GCs (icGCs) producing more permeable mucus than crypt-resident GCs. 95 Human colonic secretory progenitors and GCs subclustered into similar groups corresponding with differentiation status and marked by genes defined in mouse GC heterogeneity 95 ( Figure 10E -H). Distinct icGCs on the colon surface were visualized using immunofluorescence, with RAB27A localized to the surface GC cells ( Figure 10I ). Some mucus secretion genes (MUC2, ZG16) were expressed highest in icGCs, consistent with icGCs constitutively secreting mucus, 96 and this was supported by higher mucin 2 (MUC2) seen in surface GCs via immunofluorescence ( Figure 10I and K) . Notably, crypt-resident GCs and icGCs expressed different mucin genes ( Figure 10C ), as verified with immunofluorescence showing crypt base-specific mucin 5b (MUC5B) protein expression ( Figure 10K ) and consistent with distinct mucus production in human beings shown via lectin staining. 95 Similar SI subclusters were observed with less obvious mucin differences ( Figure 11 ). The physiological significance of this human GC heterogeneity necessitates further functional studies. EECs secrete hormones to communicate throughout the body. EEC hormone profiles have been characterized at the single-cell level in mice, using EEC reporters to enrich for this rare lineage. 97, 98 However, transcriptomic differences exist between mouse and human EECs. 97, 99 Human organoids with an EEC reporter yielded sufficient EECs for scRNAseq analysis, although potential differences from primary EECs are unclear. 97 Although several human scRNAseq studies include EECs, 4-6,9,10 our 154 EECs represent a large and informative scRNAseq data set of primary human EECs. Regional expression of hormones and other signaling machinery in EECs was surveyed ( Figure 12A-C ). An early study that immunostained regional biopsy specimens found SI-segregated Cholecystokinin (CCK), gastrin (GAST), gastric inhibitory polypeptide (GIP), neurotensin (NTS), motilin (MLN), and secretin (SCT). 100 Our data confirm this bias but additionally detected low levels of CCK, NTS, MLN, and SCT in colonic EECs, suggesting higher sensitivity of scRNAseq. Colonic NTS and CCK expression also was absent in a study analyzing region-unspecified colon, 6 emphasizing the importance of analyzing all colon regions. Fatty acid receptors FFAR1 and FFAR2 were enriched in SI EECs, with FFAR4 specific to colon ( Figure 12C ). EECs also express several hormone receptors, indicating crosstalk among EECs. Novel gut-brain crosstalk recently was described, with murine EECs forming synapses with the vagus nerve. [101] [102] [103] Thirtyone DEGs from SI and colon EECs are in the GOCC_Presynapse list ( Figure 12D ) and 33.7% of genes in the GOCC_-Presynapse list expressed highest in EECs ( Figure 12E ), suggesting a human equivalent of these mouse EECs, termed neuropods. 102 These patterns describe EEC crosstalk within the gut and between the gut and brain, further illuminating newly appreciated functional roles of EECs. EECs are classified into subtypes by hormone expression. 104 ,105 A regional breakdown of individual EECs was constructed to visualize EEC subtypes ( Figure 12F ). Enterochromaffin cells appear in each region, and ileal L cells were undetected. Multiple EECs express 8-10 hormones, expanding on studies identifying polyhormonal EECs. 106, 107 GAST and GIP largely segregated from duodenal L cells yet overlapped in jejunum. We noted rare NPY expression in MLN þ and GHRL þ EECs in jejunum and AC. Future studies combining our EECs with additional regional data sets hopefully will improve our understanding of EEC subclusters. AEs and ACCs perform nearly all intestinal absorption. 108 Three AE Leiden clusters and 2 ACC clusters were consistent with increasing maturity, reflecting other reports, 4, 9, 33 and 1 cluster largely from donor 3 ileum (AE2) separated from other AEs (Figures 1C and 13B) . A DEG signature was defined by comparing DEGs from all AEs and all ACCs. Surprisingly, only 5 DEGs were shared across SI and colonic absorptive populations ( Figure 13A ), indicating stark organ differences. AE2s expressed mature AE markers ( Figure 13B ) alongside bile acid absorption genes 109 ( Figure 13C ). It is unclear why ileal AEs of donor 3 clustered separately. Possible explanatory donor-specific demographics include donor 3 having the lowest body mass index, being the only African American, and the only donor with type II diabetes. Meal timings across donors also might induce unique expression patterns, as described for certain genes. 56, 57 Macronutrient and micronutrient handling was mapped across all AEs and ACCs ( Figure 13D ). Most fatty acid, glucose, and cholesterol transporters were SI-enriched, with regional data showing increasing expression from duodenum through ileum for most genes ( Figure 13D ). Digestive enzymes showed ileal enrichment, except for the duodenum-specific serine protease TMPRSS15/enteropeptidase. 110 Ion transporters showed the most regional differences, with SLC25A3 and SLC4A4 spanning all regions, colon-enriched SLC26A2, and SI-enriched SLC9A3R1. Finally, SCNN1 sodium transporter subunits were colon-enriched, possibly regulating colonic water uptake. This regional map expands upon previous organ-level analyses, emphasizing the importance of the ileum in digestion. Intestinal barrier function, largely conferred by celljunction proteins, is essential for well-regulated absorption and antimicrobial defense. 111 Regional mapping of the 20 highest-expressed cell junction genes ( Figure 13E ) showed equal expression of many cell-junction genes across AEs and ACCs, while others showed regional enrichment. Claudins (CLDN) are primary determinants of tight junction barrier function and epithelial integrity. 108,111 CLDN1 and CLDN15 were SI-enriched, and CLDN3, CLDN4, and CLDN7 were highest in TC. Notably, no cell junction genes were expressed highest in DC. Ulcerative colitis often originates in the distal large intestine, raising the possibility that higher junction protein expression in AC and TC might protect against certain inflammatory conditions. [112] [113] [114] Aquaporin proteins (AQPs) are the major intestinal transcellular water transporters. 115 We confirm a previous report showing increased AQP3, AQP7, and AQP11 in ileum vs colon and colon-enriched AQP8 ( Figure 13F ); however, we found AQP1 widely expressed. 6 Aquaglyceroporin (AQP3, AQP7, AQP10) expression is highest in mature AEs ( Figure 13G ) and increases from duodenum to ileum alongside lipid metabolism genes ( Figure 13D and F) . This suggests AQP-mediated glycerol transfer functions in AE triglyceride processing. We note unappreciated AQP1 specificity in ISCs and TA cells and uniquely restricted AQP8 expression in the most mature late ACCs in the AC ( Figure 13H ). These distinct differences suggest specific physiological roles that should be functionally investigated. Rare FAE cells reside in small puncta throughout the intestines. 116 FAE includes microfold (M) cells, which transport luminal antigens to resident immune cells. 117 M cells have been explored almost exclusively in mice [118] [119] [120] or using directed differentiation in vitro, 121 with only 1 scRNAseq study isolating healthy human M cells. 10 Our data set included a 19-cell cluster from a single donor (donor 2) enriched for microfold cell (M-cell) markers 122-124 and immune crosstalk genes while still expressing Epithelial Cell Adhesion Molecule (EPCAM) ( Figure 14A ). We defined 145 DEGs (Supplementary Table 1 ), finding many FAE-unique genes ( Figure 14) . Pathway enrichment analysis implicated these DEGs in immune cell interactions, verifying expected M-cell function (Supplementary Table 7) . Several murine M-cell-specific markers, 117, 123, 125 were either widely expressed or absent (Figure 14) , suggesting species functional differences. Because these data arise from a small set of cells from a single donor, future studies are necessary to fully define these cells, possibly through enriching for FAE using recently described methods. 116 We finished by designing 2 approaches showing how to find associations between lineages, receptors, and drug targets. Major receptor families were surveyed across lineages and classified as high-, intermediate-, or lowexpressing (Supplementary File 1, Supplementary Table 8 ). The 5 highest-expressing genes per family were grouped across lineages ( Figure 15A ). Several patterns appeared from these 60 receptors: 20 receptors were highest-expressed in tuft cells, 11 in EECs, 10 in AE/ACC, and 9 in FAE; 12 villi-enriched vs 3 crypt-enriched; 4 SIenriched vs 0 colon-enriched; and many uniquely marked individual lineages (12 in tuft cells, 3 in EECs, and so forth), showing potential ways to target regions and lineages. To test the novelty of these observations, we reviewed literature regarding the 12 receptors found to be unique to tuft cells. We found direct literature connections to human or mouse intestinal tuft cells for only 5 Small Intestine Colon D lineage-specific receptors arose from analyzing just 60 receptors in 1 lineage, and our full data set included 669 total receptors ( Figure 15B, Supplementary File 1) . This receptor atlas across lineages, organs, regions, and donors provides a powerful foundation to explore how extrinsic signals from local microenvironments, dietary and microbial influences, and pharmaceuticals may affect intestinal epithelial lineages. We next explored how pharmacologic agents might directly affect the intestinal epithelium. Few drugs deliberately target the intestinal epithelium [126] [127] [128] [129] and common GI side effects often are unexplained at the cell-lineage level. 130 We found 498 Food and Drug Administration-approved drugs had 232 primary gene targets expressed in our gut epithelial data set ( Figure 16A, Supplementary Table 9 ). Beyond primary targets in the gut epithelium, lineages express many enzymes that can functionalize drugs through metabolism. [127] [128] [129] We show gene expression for phase I and phase II drug metabolism enzymes by lineage with the highest expression in the intestinal epithelium ( Figure 16A ) and quantified gene expression by lineage and region (Supplementary Table 10 ). We found CES2, which metabolizes the cancer drug irinotecan into biologically active SN-38, 131 to be the highest-expressed phase I metabolism gene in the SI, with AE enrichment. Interestingly, UGT1A1, the phase II enzyme that inactivates SN-38, 132 has low gut epithelial expression (Supplementary Table 10 ). This suggests that irinotecan may experience prolonged activation in the gut, advancing the idea that orally administered irinotecan might be effective against intestinal cancers. [133] [134] [135] Our easily searchable data set quantifies the expression of genes important for intestinal metabolism of endobiotics, environmental toxicants, and pharmaceuticals. As an example of a disease-focused approach, we evaluated primary gene targets of drugs prescribed for inflammatory bowel disease (IBD). Most IBD drugs are antiinflammatory or immunomodulatory, so primary targets often are not expressed in the intestinal epithelium, yet our database shows 9 primary gene targets of 8 IBD drugs have epithelial expression ( Figure 16B ). We mapped epithelial expression of their primary target genes to locate potential off-target effects ( Figure 16C ). We found high FKBP1A, a tacrolimus (Prograf, Astellas Pharma Inc., Tokyo, Japan) target, in the little-understood BEST4 þ cells. Mycophenolate mofetil (CellCept, Genentech, South San fransisco, CA) targets IMPDH2 and IMPDH1 were expressed in proliferative crypt populations and EECs, respectively. The methotrexate target DHFR was highest in TA and progenitor cells, while the tofacitinib (Xeljanz, Pfizer, New York, NY) target JAK1 had broader expression. Because functional protein expression is not always found in the same cells as mRNA translation, especially given the quick cellular turnover of the intestine, 136 we stained for protein expression of the top 3 highest expressed gene targets that appear enriched in specific cell types: FKBP1A, IMPDH2, and DHFR. We found all 3 proteins enriched in the lineages implicated by our transcriptional data ( Figure 16D ), highlighting the usefulness of our data set for predicting drug targets. These drugs can be orally administered and primary targets in the epithelium could explain common GI side effects. [137] [138] [139] This small subset of drug targets highlights a spectrum of potential unintended epithelial effects on ISC/TA renewal, EEC hormonal regulation of appetite and gut motility, and unknown effects from other lineages. Personalized precision medicine is an emerging field motivating new technologies. 140 We used our drug-target atlas to assess regional variability of tacrolimus, mycophenolate mofetil, and tofacitinib target genes, FKBP1A, IMPDH2, and JAK1, across individual donors to inform potential patient-dependent effects ( Figure 16E ). Higher colonic expression of all 3 targets suggests that patients may experience colon-specific off-target effects. Comparing donors potentially hints at susceptibility to drug side effects, with donors 2 and 3 generally expressing target genes higher than donor 1. Although 3 donors are insufficient for statistically significant conclusions, we provide a framework to generate observations to inform larger studies. We hope our lineage-, regional-, and donor-specific data on primary drug targets will aid gastroenterology and pharmacology to better understand potential intestinal drug effects. In this study, we provide a comprehensive cell-level transcriptomic view of the SI and colon epithelium with regional resolution across multiple human beings. Our analyses independently confirm and advance prior studies, define important differences between mouse and human beings, and highlight how lineages vary along the proximal-distal axis. We include easy-to-search tables for DEGs, receptors, and drug targets that can be investigated by most investigators and trainees. Overall, our database provides a foundation for understanding individual contributions of diverse epithelial cells across the length of the human intestine and colon to maintain physiologic function. saving cost and avoiding intradonor batch effects while preserving biological variability. The hashtag antibodies also allowed for increased stringency when filtering for mutliplets and contamination. Analyzing cells across 6 regions allowed for comprehensive transcriptional signatures of genes significantly enriched in each lineage across the entire gut from 3 donors. We mapped cell cycle, mucins, hormones, transporters, digestive genes, and barrier function genes along the regions of the SI and colon. We showed drastic differences in PC growth factor expression from mouse literature and highlight the insufficiency of LYZ for uniquely marking human PCs. We used PAGA to infer a differentiation trajectory for each lineage and suggest organ-specific maturation for tuft and BEST4 þ cells. We propose novel tuft cell interactions with pathogens and the immune system. Finally, our survey of receptors and primary drug targets across lineages highlights the utility and ease of our database to find previously undescribed gene expression. The regional differences found throughout our study highlight the importance of regional selection when studying the gut, yet many colonic scRNAseq studies do not specify the sample region or mention if pooled samples are from consistent regions. We hope our database serves as a resource to understand how drugs affect the intestinal epithelium and as guidance for future precision medicine approaches. Human donor intestines were received from 3 male organ donors, aged 29, 45, and 53 years (details in Figure 2 ), from HonorBridge (Formerly Carolina Donor Services, Durham, NC) with the following acceptance criteria: age 65 years, brain-dead only, human immunodeficiency virus negative, hepatitis negative, syphilis negative, tuberculosis negative, coronavirus disease-2019 negative, and no bowel surgery, severe abdominal injury, cancer, or chemotherapy. Pancreas donors were excluded to avoid duodenum loss. The University of North Carolina Institutional Review Board determined this study does not constitute human subjects research. Intestines were transported on ice in University of Wisconsin Cold Storage Solution (Bridge to Life, Northbrook, IL). Tissue dissection began within 8 hours of crossclamping. Fat/connective tissue were trimmed and intestinal regions were separated: duodenum (most-proximal 20 cm), jejunum/ileum splitting remaining SI, and colon split into thirds for AC/TC/DC ( Figure 17 ). Two 3 Â 3 cm mucosectomies were isolated from the center of each region for dissociation. Mucosectomies were incubated in 10 mmol/L N-acetylcholine in Dulbecco's phosphate-buffered saline (dPBS) at room temperature for 30 minutes to remove mucus, then washed in ice-cold chelating buffer 141 þ 100 mmol/L Y-27632. Tissues were incubated in chelating buffer with 2 mmol/L EDTA and 0.5 mmol/L dithiothreitol, then shaken to remove crypts. High-yield shakes were pooled by region, with SI shakes pooled to approximate 1:1 villus to crypt tissue by cell mass. Crypts and villi were dissociated to single cells using 4 mg/mL Protease VIII in dPBS þ Y-27632 on ice for approximately 45 minutes with trituration via a P1000 micropipette every 10 minutes. Cells were checked under a light microscope and then filtered. Single cells were washed with dPBS þ Y-27632, resuspended in Advanced Dulbecco's modified Eagle medium/ F12 þ 1% bovine serum albumin þ Y-27632, and then stained with AnnexinV-Allophycocyanin (APC) (1:100) and 1 TotalSeq Anti-Human Hashtag Antibody (1:100, Biolegend, San Diego, CA) per region to track all 6 regions with a single library preparation. 11 Cells were washed and resuspended in Advanced Dulbecco's modified Eagle medium þ 1% bovine serum albumin þ Y-27632 for sorting on a Sony Cell Sorter SH800Z (Sony, Tokyo, Japan) to enrich for live single epithelial cells (Figure 18 ). There were 25,000 cells that passed Annexin V live/dead parameters and were fluorescence-activated cell sorter isolated for each region, then different cell hashing antibodies were added to cells from each of the 6 regions before pooling for library preparation. An additional live/dead analysis was performed after pooling and approximately 10,000 cells from the pooled population were loaded onto the Chromium Next GEM Single Cell 3' GEM, Library and Gel Bead Kit v3.1 (PN-100012, 10x Genomics, Pleasanton, CA) for complementary DNA library preparation Sequencing was performed on an Illumina NextSeq 500 (Illumina, San Diego, CA). Tissue samples adjacent to the sections dissociated for single-cell dissociation were dissected from each region and incubated with secondary antibodies in blocking buffer for 1 hour at room temperature. Finally, slides were treated with bisbenzamide (MilliporeSigma, Burlington, MA) and coverslips were mounted using Prolong Gold Antifade Reagent (Thermo Fisher Scientific, Waltham, MA). For in situ hybridization, sections were deparaffinized and rehydrated using xylenes and an ethanol gradient. In situ hybridization was performed using RNAscope (ACD Bio, Newark, CA) following the manufacturer's protocol (Table 1 lists the probes used). After the in situ hybridization, sections were co-stained for protein expression with immunofluorescence, following the protocol listed earlier, starting at the blocking step. All sections were imaged on LSM 700 and LSM710 confocal microscopes (Zeiss, Jena, Germany), and figure preparation for images was completed using FIJI (National Institutes of Health, Bethesda, MD) and Adobe Illustrator (Adobe Inc., San Jose, CA). Harmony (Harmonypy, v0.0.5) was used to integrate the top 40 principal components from each data set for clustering and visualization. 13 Leiden clustering was initialized with a k-nearest neighbor (kNN) graph (k ¼ 10 neighbors) and a Leiden resolution of 0.92 14 to resolve most expected physiological lineages ( Figure 19 ). Uniform Manifold Approximation and Projections (UMAPs) were initialized with PAGA embedding of Leiden clusters, 14,32 then nonepithelial EPCAMnegative lineages were eliminated. Regional hashtag deconvolution followed published methods: raw hashtag read counts were normalized using centered log ratio transformation followed by k-medoid clustering (k ¼ 6 medoids for donor 1, k ¼ 7 medoids for donors 2 and 3). 11 Hashtag noise distributions were determined by removing the highest-expressing cluster, then fitting a negative binomial distribution to the remaining cells. Cells were considered positive for a hashtag with counts above the distribution's 99th percentile (P < .01) threshold. Cells positive for multiple hashtags were excluded as likely doublets ( Figure 20 ). After sequencing, single-cell fastq files were aligned to reference transcriptome GRCh38 with the 10Â Cell Ranger pipeline (V4.0.0, 10x Genomics, Pleasanton, CA), and downstream analysis was performed with scanpy (v1.7.2) 142 . Annotations for cell-cycle phase predictions were added following previously published methods. 36 Quality filtering thresholds for each donor are shown in Table 2 and Figure 21 . After filtering, read counts were logtransformed and normalized to the median read depth of donor 2, which had the fewest read counts. Variability resulting from gene expression count, mitochondrial percentage, and cell-cycle gene expression were regressed out by simple linear regression. Highly variable genes were identified with the Seurat method 143 (min_dispersion, 0.2; min_mean, 0.0125; max_mean, 6), identifying 2777 genes that subsequently were used for principal component analysis. Genes were scaled to have a mean of zero and unit variance. Subclustering was performed to isolate Paneth cells from SI goblet cells, which cluster together in the overall data set. For Paneth cells, the SI_ITLN1-high cluster was subset from the main data set and 40 principal components were recalculated and reharmonized. Leiden clusters were recalculated on the new principal components based on the same 2777 highly variable genes as the initial data set with Leiden resolution of 0.15 and k ¼ 15 neighbors. Further subclustering on SI and colon goblet cells was performed to show goblet cell heterogeneity in the SI and colon separately. For colon goblet cells, Leiden clustering settings were as follows: k ¼ 5 nearest neighbors, Leiden resolution of 0.3, and 4000 highly variable genes were calculated based on 22 recomputed principal components from the colon goblet cells subset. For SI goblet cells, Leiden clustering settings were as follows: k ¼ 10 nearest neighbors, Leiden resolution of 0.4, and 2000 highly variable genes were calculated based on 19 recomputed principal components on the SI goblet cell subset. Human homologs for mouse genes were defined using Ensembl version release 104 (European [European Bioinformatics Institute, Cambridgeshire, UK] Bioinformatics Institute, Cambridgeshire, UK). 144 Pathway enrichment analysis was performed using Reactome, 91 with focus given to pathways with a false-discovery rate of less than 0.05, as calculated by over-representation analysis, and full reports are included as Supplementary Tables 3, 4, 6, and 7. Common drugs prescribed for ulcerative colitis and Crohn's disease were curated using online literature. Comprehensive receptor family lists and primary target genes for all approved drugs were downloaded from Guide to Pharmacology. 145 Phase I and phase II drug metabolism genes were defined via Reactome. 91 To infer differentiation trajectories, subclustered cell populations were separated into SI and colon as previously described. For each data set, PAGA (v1.2) then was performed on a k-nearest neighbor graph of 20 neighbors To determine genes that consistently mark a lineage, as determined by previously described Leiden clustering, in all A B Figure 21 . Filtering for cell quality. Total counts, N genes, and mitochondrial gene percentages shown for each donor before and after filtering; prefiltering (top) and postfiltering (bottom) by (A) donor and (B) region. Note differences in the Y axes between prefiltering and postfiltering rows. Duo, Duodenum; Ile, Ileum; Jej, Jejunum. 3 donors, the data set first was separated into SI-and colonspecific data. For each organ, the depth-normalized expression of each gene was used to fit to a negative binomial general linear model with the diffxpy package (v0.7.4). A Wald test was used to iterate through all cell lineages, testing a null model in which only donor-specific batch effects were included: x i ¼ b 0 þ b 1 donor against an alternative model where a cell's inclusion in the current test lineage was included as a binary independent variable, correcting for multiple testing using the Benjamini-Hochberg procedure. Each test then was repeated independently on each donor including at least 10 cells of the lineage, excluding donor as a covariate. A gene was determined to be a marker gene for a particular lineage if it met the following thresholds: (1) maximum expression in the lineage of interest, (2) q value less than 0.05 in the combined data set and all 3 donors individually, (3) minimum log 2 fold-change (compared with the next highest expressing lineage) greater than 0.25, and (4) mean in-lineage normalized expression greater than 0.2. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration Intra-and inter-cellular rewiring of the human colon during ulcerative colitis Mucosal profiling of pediatric-onset colitis and IBD reveals common pathogenics and therapeutic pathways Single-cell analysis of colonic epithelium reveals unexpected shifts in cellular composition and molecular phenotype in treatment-naïve adult Crohn's disease. Cellular and Molecular Gastroenterology and Hepatology Colonic epithelial cell diversity in health and inflammatory bowel disease Single-cell transcriptome analysis reveals differential nutrient absorption functions in human intestine Human intestinal organoids maintain self-renewal capacity and cellular diversity in niche-inspired culture condition Single-cell transcriptomics reveals immune response of intestinal cell types to viral infection Human gastrointestinal epithelia of the esophagus, stomach, and duodenum resolved at single-cell resolution Cells of the human intestinal tract mapped across space and time Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics Single-cell sequencing of developing human gut reveals transcriptional links to childhood Crohn's disease Fast, sensitive and accurate integration of single-cell data with Harmony Identification of stem cells in small intestine and colon by marker gene Lgr5 Transcription factor achaete scute-like 2 controls intestinal stem cell fate The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent 'þ4' cell markers OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells Ribosome and translational control in stem cells The regulation of rRNA gene transcription during directed differentiation of human embryonic stem cells Changes in rRNA transcription influence proliferation and cell fate within a stem cell lineage Protein synthesis rate is the predominant regulator of protein expression during differentiation Mitochondrial dynamics: biogenesis, fission, fusion, and mitophagy in the regulation of stem cell behaviors Systems-level dynamic analyses of fate change in murine embryonic stem cells Orthotopic transplantation of intestinal mucosal organoids in rodents Small intestinal stem cell identity is maintained with functional Paneth cells in heterotopically grafted epithelium onto the colon Unsupervised trajectory analysis of single-cell RNA-seq and imaging data reveals alternative tuft cell origins in the gut Dll1þ secretory progenitor cells revert to stem cells upon crypt damage Requirement of Math1 for secretory cell lineage commitment in the mouse intestine Stem cell and progenitor fate in the mammalian intestine: Notch and lateral inhibition in homeostasis and disease PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells Transcriptomics informs design of a planar human enterocyte culture system that reveals metformin enhances fatty acid export Cell cycle time and rate of entry of cells into mitosis in the small intestine of young rats Regional differences in stem and transit cell proliferation and apoptosis in the terminal ileum and colon of mice after 12 Gy Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts Mapping development of the human intestinal niche at single-cell resolution Immunohistochemical localization of epidermal growth factor in rat and man R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice Subepithelial telocytes are an important source of Wnts that supports intestinal crypts Functional intestinal stem cells after Paneth cell ablation induced by the loss of transcription factor Math1 (Atoh1) Intact function of Lgr5 receptor-expressing intestinal stem cells in the absence of Paneth cells Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells A single-cell survey of the small intestinal epithelium Targeting cancer stem cell signature gene SMOC-2 overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia Ascl2 acts as an R-spondin/ Wnt-responsive switch to control stemness in intestinal crypts Paneth cell defensins and the regulation of the microbiome: detente at mucosal surfaces Diffusion pseudotime robustly reconstructs lineage branching A uroguanylin-GUCY2C endocrine axis regulates feeding in mice Neuropeptide Y receptors; antisecretory control of intestinal epithelial function BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis Regulation of energy homeostasis by the NPY system Enhancement of sucraseisomaltase gene expression induced by luminally administered fructose in rat jejunum Control of synthesis and secretion of intestinal apolipoprotein A-IV by lipid Alpha 2-adrenoceptors in the enteric nervous system: a study in alpha 2A-adrenoceptor-deficient mice The roles of metallothioneins in carcinogenesis Metallothionein protection of cadmium toxicity Metallothionein: the multipurpose protein The Steap proteins are metalloreductases Current understanding of iron homeostasis Regulation of immune responses by tuft cells Tuft cellssystemically dispersed sensory epithelia integrating immune and neural circuitry Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit Tuft-cellderived IL-25 regulates an intestinal ILC2-epithelial response circuit Tuft cells, tastechemosensory cells, orchestrate parasite type 2 immunity in the gut Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium Murine intestinal cells expressing Trpm5 are mostly brush cells and express markers of neuronal and inflammatory cells A metabolite-triggered tuft cell-ILC2 circuit drives small intestinal remodeling Taste buds: cells, signals and synapses Taste receptor signalling -from tongues to lungs The known unknowns of antigen processing and presentation Proteasome and peptidase function in MHC-class-I-mediated antigen presentation A cell biological view of Toll-like receptor function: regulation through compartmentalization LPS/TLR4 signal transduction pathway The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition An interleukin-25-mediated autoregulatory circuit in keratinocytes plays a pivotal role in psoriatic skin inflammation SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling SIGIRR inhibits Toll-like receptor 4, 5, 9-mediated immune responses in human airway epithelial cells SIGIRR inhibits interleukin-1 receptor-and Toll-like receptor 4-mediated signaling through different mechanisms Distribution pattern and molecular signature of cholinergic tuft cells in human gastrointestinal and pancreatic-biliary tract Tuft-cell-derived leukotrienes drive rapid antihelminth immunity in the small intestine but are dispensable for anti-protist immunity Mucins in intestinal mucosal defense and inflammation: learning from clinical and experimental studies Interactions of intestinal bacteria with components of the intestinal mucus The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system Membrane mucins of the intestine at a glance Mucins, mucus, and goblet cells The reactome pathway knowledgebase Roles and regulation of the mucus barrier in the gut IL-22 promotes the formation of a MUC17 glycocalyx barrier in the postnatal small intestine during weaning Nanoarchitecture and dynamics of the mouse enteric glycocalyx examined by freeze-etching electron tomography and intravital microscopy New developments in goblet cell mucus secretion and function High-resolution mRNA and secretome atlas of human enteroendocrine cells Single cell transcriptomic profiling of large intestinal enteroendocrine cells in mice -identification of selective stimuli for insulin-like peptide-5 and glucagon-like peptide-1 co-expressing cells Comparison of human and murine enteroendocrine cells by transcriptomic and peptidomic profiling Endocrine cells in human intestine: an immunocytochemical study A gut-brain neural circuit for nutrient sensory transduction Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity Signalling in the gut endocrine axis A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry Physiology of intestinal absorption and secretion Intestinal transport and metabolism of bile acids Expression of enteropeptidase in differentiated enterocytes, goblet cells, and the tumor cells in human duodenum Claudins in intestines: distribution and functional significance in health and diseases Leaky gut: mechanisms, measurement and clinical implications in humans Recent advances in the management of distal ulcerative colitis Obesity-induces organ and tissue specific tight junction restructuring and barrier deregulation by claudin switching Expression, distribution and role of aquaporin water channels in human and animal stomach and intestines Identification, isolation and analysis of human gut-associated lymphoid tissues M cells: intelligent engineering of mucosal immune surveillance Distinct gene expression profiles characterize cellular phenotypes of follicleassociated epithelium and M cells Comprehensive gene expression profiling of Peyer's patch M cells, villous Mlike cells, and intestinal epithelial cells New approach for m-cell-specific molecules screening by comprehensive transcriptome analysis Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer's patch by expression profiling of Caco-2/Raji co-cultures Sox8 is essential for M cell maturation to accelerate IgA response at the early stage after weaning in mice M cell-dependent antigen uptake on follicle-associated epithelium for mucosal immune surveillance A unique subset of Peyer's patches express lysozyme CCL9 is secreted by the follicleassociated epithelium and recruits dome region Peyer's patch CD11bþ dendritic cells Advances in oral drug delivery for regional targeting in the gastrointestinal tract -influence of physiological, pathophysiological and pharmaceutical factors Cytochrome P450-mediated metabolism in the human gut wall Evaluation of human primary intestinal monolayers for drug metabolizing capabilities Regional differences in human intestinal drug metabolism Druginduced gastrointestinal disorders Human carboxylesterases: a comprehensive review UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors Alternative dosing schedules for irinotecan Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics Spatial discordances between mRNAs and proteins in the intestinal epithelium Tofacitinib in patients with ulcerative colitis: health-related quality of life in phase 3 randomised controlled induction and maintenance studies An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone Are innovation and new technologies in precision medicine paving a new era in patients centric care? A microengineered collagen scaffold for generating a polarized crypt-villus architecture of human small intestinal epithelium SCANPY: large-scale single-cell gene expression data analysis Spatial reconstruction of single-cell gene expression data The IUPHAR/BPS guide to pharmacology in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV guide to malaria pharmacology Czerwinski for help with dissociation and computation, Nathan Kohn and Willow Liu for assistance with dissociation, and Laurianne Van Landeghem for reviewing the manuscript. We further thank the UNC Cystic Fibrosis Center for the CFTR antibody Visualization: Lead; Writing -original draft: Lead; Writing -review & editing: Lead) Data curation: Lead; Formal analysis: Lead; Software: Lead; Visualization: Lead; Writing -original draft: Lead Data curation: Lead; Formal analysis: Lead; Software: Lead;Visualization: Lead; Writing -original draft: Supporting) Data curation: Supporting; Formal analysis: Supporting Visualization: Supporting; Writing -original draft: Supporting) Formal analysis: Supporting; Visualization: Supporting) Software: Supporting; Writing -review & editing: Supporting) Writing -review & editing: Supporting MD (Data analysis: Supporting) Conceptualization: Lead; Funding acquisition: Lead Supervision: Lead; Writing -review & editing: Equal) Python Scripts allowing for main steps of our analysis National Institutes of Health grants R01DK115806, R01DK109559 The authors first thank the organ donors without whom our study would have been impossible. The authors thank HonorBridge (formerly Carolina Donor Services) for assistance in coordinating organ donations. The authors thank Gabrielle Cannon at the Advanced Analytics core at the University of North Carolina Chapel Hill and Ashley Ezzell at the Histology Research Core at the University of North Carolina Chapel Hill. The authors thank Michael